Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
D000818:Animals; D000974:Antibodies, Antinuclear / Q000097:blood; D054414:Chemokine CCL17; D018932:Chemokine CCL2 / Q000037:antagonists & inhibitors* / Q000235:genetics; D019742:Chemokines, CC / Q000037:antagonists & inhibitors / Q000235:genetics; D018450:Disease Progression; D015870:Gene Expression; D006801:Humans; D007371:Interferon-gamma / Q000235:genetics; D007376:Interleukin-2 / Q000235:genetics; D020014:K562 Cells; D007668:Kidney / Q000098:blood supply / Q000473:pathology / Q000502:physiology; D008181:Lupus Nephritis / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D051379:Mice; D019463:Mice, Inbred MRL lpr; D013154:Spleen / Q000166:cytology; D014162:Transfection; D019737:Transplants; D014657:Vasculitis / Q000276:immunology* / Q000473:pathology / Q000628:therapy*
D000974:Antibodies, Antinuclear; C106230:CCL17 protein, human; C499538:Ccl17 protein, mouse; D054414:Chemokine CCL17; D018932:Chemokine CCL2; D019742:Chemokines, CC; D007376:Interleukin-2; D007371:Interferon-gamma